Exhibit 99.1

 

 

 

Stratasys Releases Third Quarter 2023 Financial Results

 

Revenue of $162.1 million, essentially flat with third quarter 2022, up 3.3% at constant currency excluding MakerBot and Stratasys Direct divestments

 

Record-level recurring revenue for consumables reflects strong printer utilization

 

GAAP net loss of $47.3 million, or $0.68 per diluted share, and non-GAAP net income of $2.4 million, or $0.04 per diluted share

 

Ninth straight quarter of adjusted profitability

 

Updating 2023 outlook

 

MINNEAPOLIS & REHOVOT, Israel - (BUSINESS WIRE) - November 16, 2023 - Stratasys Ltd. (Nasdaq: SSYS) (“Stratasys” or the “Company”), a leader in polymer 3D printing solutions, today announced financial results for the third quarter 2023.

 

Third Quarter 2023 Financial Results Compared to Third Quarter 2022:

 

Revenue of $162.1 million compared to $162.2 million.

 

GAAP gross margin of 40.5%, compared to 43.6%.

 

Non-GAAP gross margin of 48.3%, compared to 48.5%.

 

GAAP operating loss of $42.8 million, which includes $17.3 million of costs related to merger and acquisition activities, defense against hostile tender offer, proxy contest and related professional fees, compared to an operating loss of $15.6 million.

 

Non-GAAP operating income of $4.1 million, compared to $4.5 million.

 

GAAP net loss of $47.3 million, or $0.68 per diluted share, compared to net income of $18.7 million, or $0.28 per diluted share, which net income in Q3 2022 included a one-time $39.1M gain from the MakerBot deconsolidation.

 

Non-GAAP net income of $2.4 million, or $0.04 per diluted share, compared to $3.3 million, or $0.05 per diluted share.

 

Adjusted EBITDA of $9.8 million, compared to $9.9 million.

 

Cash used in operations of $12.7 million, compared to $18.4 million in the year-ago quarter, due to the costs related to mergers and acquisitions activities, defense against a hostile tender offer, a proxy contest and related professional fees. Excluding these one-time payments, operating cash flow for the third quarter of 2023 would have been positive.

 

Dr. Yoav Zeif, Stratasys’ Chief Executive Officer stated, “During the third quarter, Stratasys delivered solid operating and financial results, highlighted by record recurring revenues from consumables, reflecting solid printer utilization. Our relentless focus on execution allowed us to deliver comparable results to the year-ago quarter for revenues, non-GAAP margins and adjusted EBITDA, as well as our ninth consecutive quarter of positive adjusted earnings per share.”

 

Dr. Zeif continued, “We want to acknowledge the tremendous support we have received from partners, customers, investors and our industry since the tragic events in Israel. We especially want to thank our employees who have performed in an exemplary fashion during these challenging times. Our operations have been fully functional, allowing us to continue delivering industry-leading results. We have streamlined and focused our business, while simultaneously rolling out new and exciting innovations that will expand our leadership position across systems, materials, software and customer service. Our recently introduced F3300 is the latest step in that continued evolution to unlock manufacturing benefits for our customers. Our maturity as a company, financial discipline and resilient business model position us well to deliver exceptional value for many years to come.”

 

1

 

 

 

 

2023 Financial Outlook:

 

Based on the divestitures in Stratasys Direct, as well as macroeconomic uncertainty in its end markets, the Company is updating its revenue guidance and its outlook for the remainder of 2023 as follows:

 

Full year revenue of $620 million to $630 million.

 

Full year non-GAAP gross margins of 48.0% to 49.0%.

 

Full year non-GAAP operating expenses in a range of $288 million to $290 million.

 

Full year non-GAAP operating margins in a range of 2.0% to 2.5%.

 

GAAP net loss of $117 million to $104 million, or ($1.70) to ($1.51) per diluted share.

 

oIncludes one-time extraordinary costs associated with defense of tender offer and proxy contest, and merger-related activities.

 

Non-GAAP net income of $6 million to $9 million, or $0.10 to $0.14 per diluted share.

 

Adjusted EBITDA of $35 million to $38 million.

 

Capital expenditures of $15 million to $20 million.

 

2023 non-GAAP earnings guidance excludes $112 million to $121 million of expenses attributable to projected amortization of intangible assets, share-based compensation expense, and reorganization and other expenses (including the one-time extraordinary costs referenced above). 2023 non-GAAP guidance includes tax adjustments of $2 million to $3 million on the above non-GAAP items.

 

Appropriate reconciliations between GAAP and non-GAAP financial measures are provided in a table at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures.

 

Stratasys Ltd. Third Quarter 2023 Webcast and Conference Call Details

 

The Company plans to webcast its conference call to discuss its third quarter 2023 financial results on Thursday, November 16, 2023, at 10:00 a.m. (ET).

 

The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com, or directly at the following web address:

 

https://event.choruscall.com/mediaframe/webcast.html?webcastid=bSk6aoYV

 

To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at investors.stratasys.com, or by accessing the above-provided web address.

 

Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products, healthcare, fashion and education. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.

 

2

 

 

 

 

To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, X.com (formerly Twitter), LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the Company’s websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

 

Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.

 

Cautionary Statement Regarding Forward-Looking Statements

 

The statements in this press release regarding Stratasys’ strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2023 and beyond, are forward-looking statements reflecting management’s current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys’ business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; the outcome of our board’s comprehensive process to explore strategic alternatives for our company; the degree to which our company’s operations remain resistant to potential adverse effects of Israel’s war against the terrorist organization Hamas; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating and integrating into our existing business acquisitions or investments in new businesses, technologies, products or services; the global macro-economic environment, including headwinds caused by inflation, high interest rates, unfavorable currency exchange rates and potential recessionary conditions; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular; costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others’ intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2022, which we filed with the U.S. Securities and Exchange Commission, or SEC, on March 3, 2023 (the “2022 Annual Report”). Readers are urged to carefully review and consider the various disclosures made throughout our 2022 Annual Report and the Report of Foreign Private Issuer on Form 6-K that attaches Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition for the third quarter and first nine months of 2023, which will be furnished to the SEC on or about the date hereof, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

3

 

 

 

 

Use of Non-GAAP Financial Measures

 

The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, and legal provisions and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.

 

Yonah Lloyd

 

CCO & VP Investor Relations

 

Yonah.Lloyd@stratasys.com

 

Source: Stratasys Ltd.

 

4

 

 

Stratasys Ltd.

 

Consolidated Balance Sheets

 

(Unaudited)

 

(in thousands, except share data)        

 

   September 30,   December 31, 
   2023   2022 
ASSETS        
           
Current assets          
Cash and cash equivalents  $104,563   $150,470 
Short-term deposits   80,000    177,367 
Accounts receivable, net of allowance for credit losses of $1.4 million and $0.9 million as of September 30, 2023 and December 31, 2022, respectively    164,075    144,739 
Inventories   197,420    194,054 
Prepaid expenses   9,732    5,767 
Other current assets   27,534    27,823 
           
Total current assets   583,324    700,220 
           
Non-current assets          
Property, plant and equipment, net   198,272    195,063 
Goodwill   90,187    64,953 
Other intangible assets, net   141,201    121,402 
Operating lease right-of-use assets   19,533    18,122 
Long-term investments   129,738    141,610 
Other non-current assets   19,510    18,420 
           
Total non-current assets   598,441    559,570 
           
Total assets  $1,181,765   $1,259,790 
           
LIABILITIES AND EQUITY          
           
Current liabilities          
Accounts payable  $60,845   $72,921 
Accrued expenses and other current liabilities   49,817    45,912 
Accrued compensation and related benefits   31,502    34,432 
Deferred revenues - short term   51,751    50,220 
Operating lease liabilities - short term   6,511    7,169 
           
Total current liabilities   200,426    210,654 
           
Non-current liabilities          
Deferred revenues - long term   28,559    25,214 
Deferred income taxes - long term   6,889    5,638 
Operating lease liabilities - long term   12,692    10,670 
Contingent consideration   25,884    23,707 
Other non-current liabilities   24,172    24,475 
           
Total non-current liabilities   98,196    89,704 
           
Total liabilities   298,622    300,358 
           
Equity          
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 69,165 shares and 67,086 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively   194    187 
Additional paid-in capital   3,080,877    3,048,915 
Accumulated other comprehensive loss   (12,958)   (12,818)
Accumulated deficit   (2,184,970)   (2,076,852)
Total equity   883,143    959,432 
           
Total liabilities and equity  $1,181,765   $1,259,790 

 

5

 

 

Stratasys Ltd.

 

Consolidated Statements of Operations

 

(in thousands, except per share data)

                   

   Three Months Ended September 30,   Nine Months Ended September 30, 
   2023   2022   2023   2022 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
Net sales                
Products  $113,270   $112,133   $323,353   $340,927 
Services   48,863    50,059    147,908    151,297 
    162,133    162,192    471,261    492,224 
                     
Cost of sales                    
Products   59,546    55,916    168,235    176,421 
Services   36,938    35,527    105,760    107,984 
    96,484    91,443    273,995    284,405 
                     
Gross profit   65,649    70,749    197,266    207,819 
                     
Operating expenses                    
Research and development, net   23,567    23,145    69,347    71,489 
Selling, general and administrative   84,880    63,230    221,173    195,085 
    108,447    86,375    290,520    266,574 
                     
Operating loss   (42,798)   (15,626)   (93,254)   (58,755)
                     
Gain from deconsolidation of subsidiary   -    39,136    -    39,136 
Financial income (expenses), net   687    452    2,147    (2,080)
                     
Income (loss) before income taxes   (42,111)   23,962    (91,107)   (21,699)
                     
Income tax expenses   (645)   (3,298)   (5,145)   (2,796)
                     
Share in losses of associated companies   (4,523)   (1,915)   (11,866)   (2,089)
                     
Net income (loss)  $(47,279)  $18,749   $(108,118)  $(26,584)
                     
Net income (loss) per share                    
Basic  $(0.68)  $0.28   $(1.58)  $(0.40)
Diluted  $(0.68)  $0.28   $(1.58)  $(0.40)
                     
Weighted average ordinary shares outstanding                    
Basic   69,093    66,772    68,432    66,356 
Diluted   69,093    67,038    68,432    66,356 

 

6

 

 

     Three Months Ended September 30, 
      2023   Non-GAAP   2023   2022   Non-GAAP   2022 
      GAAP   Adjustments   Non-GAAP   GAAP   Adjustments   Non-GAAP 
      U.S. dollars and shares in thousands (except per share amounts) 
   Gross profit (1)  $65,649   $12,617   $78,266   $70,749   $7,990   $78,739 
   Operating income (loss) (1,2)   (42,798)   46,885   $4,087    (15,626)   20,149    4,523 
   Net income (loss) (1,2,3)   (47,279)   49,725   $2,446    18,749    (15,423)   3,326 
   Net income (loss) per diluted share (4)  $(0.68)  $0.72   $0.04   $0.28   $(0.23)  $0.05 
                                  
(1)  Acquired intangible assets amortization expense        5,142              6,941      
   Non-cash stock-based compensation expense        891              1,061      
   Restructuring and other related costs        6,584              (12)     
            12,617              7,990      
                                  
(2)  Acquired intangible assets amortization expense        2,599              2,138      
   Non-cash stock-based compensation expense        6,588              6,330      
   Restructuring and other related costs        2,360              1,309      
   Revaluation of investments        4,300              901      
   Contingent consideration        265              394      
   Legal, consulting and other expenses        18,156              1,087      
            34,269              12,159      
            46,885              20,149      
                                  
(3)  Corresponding tax effect        153              2,993      
   Finance expenses        162              -      
   Equity method related amortization and other        2,525              571      
   Gain from deconsolidation of Subsidiary                       (39,136)     
           $49,725             $(15,423)     
                                  
(4)  Weighted average number of ordinary shares outstanding- Diluted   69,093         69,815    67,038         67,038 

 

7

 

 

      Nine Months Ended September 30, 
      2023   Non-GAAP   2023   2022   Non-GAAP   2022 
      GAAP   Adjustments   Non-GAAP   GAAP   Adjustments   Non-GAAP 
      U.S. dollars and shares in thousands (except per share amounts) 
   Gross profit (1)  $197,266   $29,199   $226,465   $207,819   $27,593   $235,412 
   Operating income (loss) (1,2)   (93,254)   103,866   $10,612    (58,755)   67,235   $8,480 
   Net income (loss) (1,2,3)   (108,118)   114,179   $6,061    (26,584)   32,295   $5,711 
   Net income (loss) per diluted share (4)  $(1.58)  $1.67   $0.09   $(0.40)  $0.49   $0.09 
                                  
(1)  Acquired intangible assets amortization expense        14,157              20,861      
   Non-cash stock-based compensation expense        2,822              3,041      
   Restructuring and other related costs        12,220              3,691      
            29,199              27,593      
                                  
(2)  Acquired intangible assets amortization expense        7,479              6,581      
   Non-cash stock-based compensation expense        20,920              21,714      
   Restructuring and other related costs        6,626              1,864      
   Revaluation of investments        4,880              3,217      
   Contingent consideration        877              1,197      
   Legal, consulting and other expenses        33,885              5,069      
            74,667              39,642      
            103,866              67,235      
                                  
(3)  Corresponding tax effect        3,404              3,219      
   Finance expenses        1,827              571      
   Equity method related amortization and other        5,081              406      
   Gain from deconsolidation of Subsidiary        -              (39,136)     
           $114,179             $32,295      
                                  
(4)  Weighted average number of ordinary shares outstanding- Diluted   68,432         69,046    66,356         67,007 

  

 

 

8